Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.
暂无分享,去创建一个
L. Potters | J. Ciezki | C. Reddy | E. Klein | P. Kupelian | T. Carlson | D. Khuntia | Alwyn M. Reuther
[1] B. Trock,et al. A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria. , 2002, The Journal of urology.
[2] Juni Palmgren,et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. , 2002, The New England journal of medicine.
[3] L. Holmberg,et al. Quality of life after radical prostatectomy or watchful waiting. , 2002, The New England journal of medicine.
[4] C. Reddy,et al. Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] George Starkschall,et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. , 2002, International journal of radiation oncology, biology, physics.
[6] John E Tomaszewski,et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era , 2002, Cancer.
[7] A. Hanlon,et al. Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer. , 2002, International journal of radiation oncology, biology, physics.
[8] C. Reddy,et al. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. , 2002, International journal of radiation oncology, biology, physics.
[9] D. Brachman,et al. Failure free survival following brachytherapy alone for prostate cancer: comparison with external beam radiotherapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[10] M. Kattan,et al. The definition of biochemical failure in patients treated with definitive radiotherapy. , 2000, International journal of radiation oncology, biology, physics.
[11] D. Brachman,et al. Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice. , 2000, International journal of radiation oncology, biology, physics.
[12] L. Potters. Permanent prostate brachytherapy: lessons learned, lessons to learn. , 2000, Oncology.
[13] J. Blasko,et al. Permanent source brachytherapy for prostate cancer. American College of Radiology. ACR Appropriateness Criteria. , 2000, Radiology.
[14] Ravinder Nath,et al. American Brachytherapy Society recommendations for clinical implementation of NIST-1999 standards for 103palladium brachytherapy , 2000 .
[15] L. Potters,et al. The role of external beam irradiation in patients undergoing prostate brachytherapy. , 2000, Urologic oncology.
[16] C. Reddy,et al. Higher than standard radiation doses (> or =72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. , 2000, International journal of radiation oncology, biology, physics.
[17] E. Klein,et al. Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results. , 1999, Urology.
[18] P. Grimm,et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. , 1999, International journal of radiation oncology, biology, physics.
[19] A W Partin,et al. Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.
[20] W. Catalona,et al. Retrospective comparison of radical retropubic prostatectomy and 125iodine brachytherapy for localized prostate cancer. , 1999, The Journal of urology.
[21] A. Renshaw,et al. Biochemical Outcome after radical prostatectomy, external beam Radiation Therapy, or interstitial Radiation therapy for clinically localized prostate cancer , 1998 .
[22] William R. Fair,et al. DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER , 1998 .
[23] P. Walsh,et al. Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis. , 1998, Urology.
[24] D. Paulson. Radical perineal prostatectomy. , 1998, Current opinion in urology.
[25] J. Blasko,et al. Interstitial iodine‐125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma , 1997, Cancer.
[26] A. D'Amico,et al. Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml. , 1997, International journal of radiation oncology, biology, physics.
[27] James D. Cox,et al. Consensus statement: Guidelines for PSA following radiation therapy , 1997 .
[28] G. Hanks. More on the Uro-Oncology Research Group report of radical surgery vs. radiotherapy for adenocarcinoma of the prostate. , 1988, International journal of radiation oncology, biology, physics.
[29] T. Stamey,et al. Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate , 1987 .
[30] W Hinshaw,et al. Radical surgery versus radiotherapy for adenocarcinoma of the prostate. , 1982, The Journal of urology.
[31] C. Iselin,et al. Radical perineal prostatectomy: oncological outcome during a 20-year period. , 1999, The Journal of urology.
[32] P. Walsh,et al. Radical prostatectomy for the treatment of localized prostatic carcinoma. , 1980, The Urologic clinics of North America.